719PGemcitabine plus afatinib versus gemcitabine alone in metastatic pancreatic cancer: An explorative randomized AIO phase II trial (ACCEPT)
Michael Haas,Dirk Waldschmidt,M Stahl,Anke Reinacher-Schick,F Kaiser,Stephan Kanzler,N Frickhofen,Thomas Seufferlein,T Dechow, R J C Mahlberg,Peter Malfertheiner,G Illerhaus,S Kubicka,Swantje Held,C B Westphalen,Stephan Kruger,Stefan Boeck,Volker Heinemann ANNALS OF ONCOLOGY（2018）
AI 理解论文
溯源树
样例
